Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Curry plum leaf (Flacourtia jangomas) contains bioactive phenolic compounds and flavonoids that modulate hepatic glucose metabolism and enhance Phase II liver detoxification enzymes. The prebiotic fibers and phytochemicals support beneficial gut microbiota while providing anti-inflammatory activity through cyclooxygenase inhibition.
Reported Benefits (Provisional)
Origin & History
Flacourtia jangomas, commonly known as the Curry Plum or Indian plum, is a fruit-bearing tree native to the tropical forests and dry woodlands of South Asia, Southeast Asia, and parts of Australia. Valued for its unique flavor profile and traditional medicinal uses, it offers significant benefits for metabolic and digestive health.
Research Narrative (Provisional)
Preliminary research, including in vitro and animal studies, supports the Curry Plum's potential for metabolic regulation, liver detoxification, and antioxidant activity. Emerging evidence suggests benefits for gut health and immune function, aligning with its traditional uses. Further human clinical trials are needed to confirm these effects.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber (prebiotic) - Vitamin C - Magnesium - Potassium - Zinc - Iron - Flavonoids (quercetin, catechins, kaempferol, anthocyanins) - Polyphenols (tannins, ellagic acid) - Bioactive Alkaloids - Saponins - Plant Sterols - Digestive Enzymes
Reported Mechanism (Provisional)
The phenolic compounds in curry plum leaf enhance hepatic glucokinase activity and inhibit glucose-6-phosphatase, improving glucose homeostasis. Flavonoids activate Phase II detoxification enzymes including glutathione S-transferase and UDP-glucuronosyltransferase in liver tissue. The prebiotic oligosaccharides promote beneficial Lactobacillus and Bifidobacterium proliferation while inhibiting pro-inflammatory cytokine production via NF-κB pathway modulation.
Clinical Narrative (Provisional)
Current evidence derives primarily from preliminary in vitro studies examining antioxidant capacity and enzyme activity, plus limited animal models investigating metabolic parameters. No peer-reviewed human clinical trials have been published specifically on Flacourtia jangomas leaf extracts. Animal studies suggest potential benefits for glucose tolerance and liver function markers, but sample sizes remain small (n=20-40 subjects). The strength of evidence is currently insufficient to support definitive therapeutic claims pending controlled human trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.